Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1571-1577

  Tu, Kangsheng ^a   Li, Chao ^a   Zheng, Xin ^a   Yang, Wei ^a   Yao, Yingmin ^a   Liu, Qingguang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

BMI 1; Hepatocellular carcinoma; miR 218; Prognosis; Tumor progression

Indexed keywords

BMI1 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; MIRN218 MICRORNA, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER NEOPLASMS; LIVER RESECTION; METABOLISM; MIDDLE AGED; NUDE MOUSE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM TRANSPLANTATION; POLYCOMB REPRESSIVE COMPLEX 1; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84907843387     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3386     Document Type: Article

References (26)

1. Tu K, Zheng X, Zan X, Han S, Yao Y and Liu Q: Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma. Hepatol Res 42: 904-910, 2012.
2. Tu K, Zheng X, Zhou Z, et al: Recombinant human adenovirusp53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS One 8: e68574, 2013.
3. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
4. Jia Z, Wang K, Wang G, Zhang A and Pu P: MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7. PLoS One 8: e55008, 2013.
5. Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73: 473-477, 2013.
6. Wong CM, Kai AK, Tsang FH and Ng IO: Regulation of hepatocarcinogenesis by microRNAs. Front Biosci 5: 49-60, 2013.
7. Gramantieri L, Fornari F, Callegari E, et al: MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 12: 2189-2204, 2008.
8. Davidson MR, Larsen JE, Yang IA, et al: MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 5: e12560, 2010.
9. Chiyomaru T, Enokida H, Kawakami K, et al: Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 30: 434-443, 2012.
10. Song L, Huang Q, Chen K, et al: miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-βBiochem Biophys Res Commun 402: 135-140, 2010.
11. Tie J, Pan Y, Zhao L, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
12. Li J, Ping Z and Ning H: MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer. Int J Mol Sci 13: 16053-16064, 2012.
13. He X, Dong Y, Wu CW, et al: MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 18: 1491-1498, 2012.
14. Leite KR, Sousa-Canavez JM, Reis ST, et al: Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 29: 265-269, 2011.
15. Uesugi A, Kozaki K, Tsuruta T, et al: The tumor suppressive microRNA miR- 218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 71: 5765-5778, 2011.
16. Li BS, Zhao YL, Guo G, et al: Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 7: e41629, 2012.
17. Zheng X, Gai X, Ding F, Lu Z, Tu K, Yao Y and Liu Q: Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Mol Cancer 12: 96, 2013.
18. Tu K, Zheng X, Yin G, Zan X, Yao Y and Liu Q: Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD. Mol Med Rep 6: 525-530, 2012.
19. Kang MK, Kim RH, Kim SJ, et al: Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 96: 126-133, 2007. (Pubitemid 46094649)
20. Zhu Z, Xu Y, Du J, Tan J and Jiao H: Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. J Surg Oncol 109: 89-94, 2014.
21. Tu Y, Gao X, Li G, et al: MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 73: 6046-6055, 2013.
22. Tong YQ, Liu B, Zheng HY, He YJ, Gu J, Li F and Li Y: Overexpression of BMI-1 is associated with poor prognosis in cervical cancer. Asia Pac J Clin Oncol 8: e55-e62, 2012.
23. Yin T, Wei H, Leng Z, et al: Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells. Chemotherapy 57: 488-496, 2011.
24. Schuringa JJ and Vellenga E: Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Curr Opin Hematol 17: 294-299, 2010.
25. Douglas D, Hsu JH, Hung L, et al: BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression. Cancer Res 68: 6507-6515, 2008.
26. Li X, Yang Z, Song W, et al: Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/ PI3K/Akt pathway. Int J Oncol 43: 793-802, 2013.